Daniel Araujo
University of Florida
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Daniel Araujo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:58 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07917390 · ALT-100 Monoclonal Antibody (mAb) in Bone-Predominant Metastatic Androgen Pathway Modulation Resistant (APMR) Prostate Cancer -- The ALTAR-100 TrialUniversity of Florida · not yet recruiting · Prostate Cancer Metastatic to Bone · principal investigator
- Ph2NCT07643519 · Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial CarcinomaUniversity of Florida · not yet recruiting · Urothelial Carcinoma (UC) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:58 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:58 UTC. The ranking covers the 200 most relevant of 72 PubMed records, and a shared surname and initials can bring in a namesake. All 72 on PubMed
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.Psychol Med · 2019539 citationsRCR 31.4
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.J Clin Psychopharmacol · 2016333 citationsRCR 15.8
- 279 citationsRCR 29.8
- Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.Nat Med · 2023183 citationsRCR 13.0
- Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator.Arthritis Rheum · 2007182 citationsRCR 6.1
- 167 citationsRCR 5.0
- 147 citationsRCR 5.6
- Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.Lancet Oncol · 2022142 citationsRCR 9.9
- Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).Cancer · 2013135 citationsRCR 4.6
- Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor.Ann Oncol · 201082 citationsRCR 2.2